Article

Artificial Intelligence in Multiple Myeloma: From Diagnostics and Clinical Trials to Drug Discovery

2026-05-15

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Multiple myeloma is a heterogeneous plasma cell malignancy that demands increasingly complex diagnostic and therapeutic decision-making. Artificial intelligence (AI) is rapidly reshaping the myeloma care continuum, offering new opportunities to improve outcomes across the full care pathway. <bold>Main text:</bold> We review four domains of AI application in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7bcfb3f8-490f-5bef-95f5-0c3e2fdef5bb
DOI: 10.21203/rs.3.rs-9712876/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Artificial Intelligence in Multiple Myeloma: From Diagnostics and Clinical Trials to Drug DiscoveryDOI 10.21203/rs.3.rs-9712876/v1Read

Advancements in Multiple Myeloma Research: High-Throughput Sequencing Technologies, Omics, and the Role of Artificial IntelligenceSemantic proximity Read

Artificial Intelligence (AI) and Machine Learning (ML) in Diagnosing Cancer: Current TrendsSemantic proximity Read

“MyeGPT: an AI agent for Multiple Myeloma”Semantic proximity Read

Challenges, Difficulties, and Delayed Diagnosis of Multiple MyelomaSemantic proximity Read

Integrating Omics Data and AI for Cancer Diagnosis and Prognosis: A Systematic ReviewSemantic proximity Read

AI-Powered Diagnosis: A New Weapon Against Cancer and Microbial InfectionsSemantic proximity Read

A Comprehensive Targeted Panel of 295 Genes: Unveiling Key Disease Initiating and Transformative Biomarkers in Multiple MyelomaSemantic proximity Read

Precision Oncology in the Era of Genomics and Artificial IntelligenceSemantic proximity Read

Unsupervised Multiomics Integration Identifies Prognostic Subtypes and Druggable Vulnerabilities in Multiple MyelomaSemantic proximity Read

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity Read

Machine Learning Models for Predicting Multiple Myeloma Staging and MGUS Progression Using Gene Expression DataSemantic proximity Read

Individualized dynamic risk assessment for multiple myelomaSemantic proximity Read